MASCC practice statement: topical corticosteroids are recommended to prevent acute radiation dermatitis in selected high-risk head and neck and breast cancer patients and to treat early dermatitis without moist desquamation; medium-potency agents preferred.
Guideline
Wong et al. MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids